| scholarly article | Q13442814 |
| P2093 | author name string | Jing Nie | |
| E Helene Sage | |||
| P2860 | cites work | Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin | Q38408437 |
| Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases | Q40184809 | ||
| SPARC represses E-cadherin and induces mesenchymal transition during melanoma development | Q40248571 | ||
| Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro | Q40307786 | ||
| Changes in integrin expression during adipocyte differentiation | Q40375216 | ||
| Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. | Q40638066 | ||
| Osteonectin-Null Mutation Compromises Osteoblast Formation, Maturation, and Survival | Q40647978 | ||
| The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase | Q41889041 | ||
| Expression and purification of recombinant human SPARC produced by baculovirus | Q42055562 | ||
| Lenses of SPARC-null mice exhibit an abnormal cell surface-basement membrane interface | Q42492949 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Differentiation-dependent expression of laminin-8 (alpha 4 beta 1 gamma 1) mRNAs in mouse 3T3-L1 adipocytes | Q42833926 | ||
| Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells | Q43539828 | ||
| The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. | Q43668487 | ||
| SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength | Q44465718 | ||
| Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro | Q44914125 | ||
| Absence of SPARC in murine lens epithelium leads to increased deposition of laminin-1 in lens capsule | Q44915224 | ||
| Understanding adipocyte differentiation | Q46119331 | ||
| Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse | Q46477839 | ||
| Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies | Q47585053 | ||
| SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells | Q48364943 | ||
| Extracellular matrix substrata alter adipocyte yield and lipogenesis in primary cultures of stromal-vascular cells from human adipose. | Q51722962 | ||
| SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. | Q52536817 | ||
| Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. | Q54611050 | ||
| Modulation of Rho GTPase Signaling Regulates a Switch between Adipogenesis and Myogenesis | Q57363725 | ||
| Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation | Q79872865 | ||
| Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma | Q79918319 | ||
| Inhibition of adipogenesis by Wnt signaling | Q22254771 | ||
| The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors | Q24563124 | ||
| Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase | Q24682825 | ||
| Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells | Q28276215 | ||
| Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells | Q28344025 | ||
| Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation | Q28505419 | ||
| APC-dependent suppression of colon carcinogenesis by PPARgamma | Q28506424 | ||
| Mitotic clonal expansion: a synchronous process required for adipogenesis | Q28588756 | ||
| Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription | Q31462537 | ||
| SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity | Q33222107 | ||
| Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytes | Q33319636 | ||
| IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells | Q33347082 | ||
| Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. | Q33688041 | ||
| Transient induction of ENC-1, a Kelch-related actin-binding protein, is required for adipocyte differentiation | Q33903282 | ||
| Molecular regulation of adipogenesis | Q34059685 | ||
| SPARC, a matricellular protein: at the crossroads of cell-matrix communication | Q34164765 | ||
| Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A | Q34331369 | ||
| Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. | Q34413514 | ||
| SPARC-null mice exhibit increased adiposity without significant differences in overall body weight | Q35022737 | ||
| Runx2/Cbfa1: A Multifunctional Regulator of Bone Formation | Q35552258 | ||
| Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. | Q35725912 | ||
| Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications | Q35771868 | ||
| Laminin functions in tissue morphogenesis. | Q35912792 | ||
| Regulation of PPARgamma activity during adipogenesis | Q36042255 | ||
| PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors | Q36234340 | ||
| Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation | Q36324592 | ||
| Laminin polymerization induces a receptor-cytoskeleton network | Q36342173 | ||
| Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation | Q36364880 | ||
| A Wnt canon orchestrating osteoblastogenesis | Q36391330 | ||
| Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation | Q36872312 | ||
| Osteopenia and decreased bone formation in osteonectin-deficient mice | Q37176145 | ||
| The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. | Q38302172 | ||
| Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells | Q38331308 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adipogenesis | Q2824461 |
| P304 | page(s) | 1279-1290 | |
| P577 | publication date | 2008-11-05 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling | |
| P478 | volume | 284 |
| Q34808686 | A role for SPARC in the moderation of human insulin secretion |
| Q24627461 | Adipocyte extracellular matrix composition, dynamics and role in obesity |
| Q35669821 | Adipose progenitor cells reside among the mature adipocytes: morphological research using an organotypic culture system |
| Q35799820 | Age-related resistance of skeletal muscle-derived progenitor cells to SPARC may explain a shift from myogenesis to adipogenesis |
| Q48035831 | An extract from pork bones containing osteocalcin improves glucose metabolism in mice by oral administration. |
| Q35116107 | Anti-cancer role of SPARC, an inhibitor of adipogenesis |
| Q37848921 | Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue |
| Q36412223 | Association of serum SPARC level with severity of coronary artery lesion in type 2 diabetic patients with coronary heart disease |
| Q83631277 | Astrocytes control glutamate receptor levels at developing synapses through SPARC-beta-integrin interactions |
| Q34547034 | Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork |
| Q90669233 | Circulating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMS |
| Q37245971 | Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content |
| Q35653088 | ECM roles in the function of metabolic tissues. |
| Q35069694 | Elevated plasma SPARC levels are associated with insulin resistance, dyslipidemia, and inflammation in gestational diabetes mellitus |
| Q50915639 | Exercise-induced myokines in health and metabolic diseases. |
| Q57029307 | Fat fibrosis: friend or foe? |
| Q49911816 | GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice |
| Q45983953 | Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC. |
| Q44957927 | Inactivation of SPARC enhances high-fat diet-induced obesity in mice |
| Q84926939 | Inflammation: where is the SPARC in adipose-tissue inflammation? |
| Q90050056 | Irisin Exerts Inhibitory Effect on Adipogenesis Through Regulation of Wnt Signaling |
| Q58799586 | Knockdown of FOXA2 enhances the osteogenic differentiation of bone marrow-derived mesenchymal stem cells partly via activation of the ERK signalling pathway |
| Q83559122 | Knockdown of SPARC leads to decreased cell-cell adhesion and lens cataracts during post-gastrula development in Xenopus laevis |
| Q27336438 | Laminin α4 deficient mice exhibit decreased capacity for adipose tissue expansion and weight gain |
| Q89622417 | Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer |
| Q30422650 | Loss of SPARC in bladder cancer enhances carcinogenesis and progression |
| Q35542423 | Matricellular proteins in cardiac adaptation and disease |
| Q42096914 | Matricellular proteins: an overview |
| Q38857139 | Microenvironmental Control of Adipocyte Fate and Function. |
| Q38199932 | Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. |
| Q37926599 | New insights into adipose tissue dysfunction in insulin resistance |
| Q35674489 | Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats |
| Q41002949 | Pleiotropic roles of the matricellular protein Sparc in tendon maturation and ageing |
| Q50921433 | Profibrotic Infrapatellar Fat Pad Remodeling Without M1 Macrophage Polarization Precedes Knee Osteoarthritis in Mice With Diet-Induced Obesity. |
| Q40527980 | Proteolytic Isoforms of SPARC Induce Adipose Stromal Cell Mobilization in Obesity |
| Q42774497 | RNA-seq analysis of bovine intramuscular, subcutaneous and perirenal adipose tissues |
| Q37267107 | Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose |
| Q35233858 | Revisiting the matricellular concept |
| Q38137862 | Role of SPARC in bone remodeling and cancer-related bone metastasis. |
| Q27309073 | SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane |
| Q42643959 | SPARC functions as an inhibitor of adipogenesis |
| Q100694445 | SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells |
| Q37679943 | SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome |
| Q39431361 | SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin |
| Q37701264 | SPARC: a key player in the pathologies associated with obesity and diabetes. |
| Q47588064 | SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex |
| Q41183233 | Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer. |
| Q42362739 | Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer. |
| Q35080462 | Secreted protein acidic and rich in cysteine internalization and its age-related alterations in skeletal muscle progenitor cells |
| Q94465731 | Site-Dependent Lineage Preference of Adipose Stem Cells |
| Q35122148 | Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles. |
| Q47605958 | The Absence of Laminin α4 in Male Mice Results in Enhanced Energy Expenditure and Increased Beige Subcutaneous Adipose Tissue |
| Q45823378 | The Xenopus Tgfbi is required for embryogenesis through regulation of canonical Wnt signalling. |
| Q35617688 | The delayed recovery of the remobilized rat tibialis anterior muscle reflects a defect in proliferative and terminal differentiation that impairs early regenerative processes |
| Q42709950 | The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling |
| Q37913130 | The regulatory function of SPARC in vascular biology |
| Q37607131 | The role of SPARC in extracellular matrix assembly |
| Q47362763 | The role of exercise-induced myokines in regulating metabolism. |
| Q41933144 | The role of thrombospondin (TSP)-1 in obesity and diabetes |
| Q37093613 | Thrombospondin-1 regulates adiposity and metabolic dysfunction in diet-induced obesity enhancing adipose inflammation and stimulating adipocyte proliferation |
| Q34127148 | Thrombospondin-2 is an endogenous adipocyte inhibitor. |
Search more.